Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo - PubMed (original) (raw)
Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo
F Laszlo et al. Eur J Pharmacol. 1995.
Abstract
The effects of aminoguanine on the intestinal vascular permeability following endotoxin administration in vivo has been compared to those of the nitric oxide (NO) synthase inhibitor NG-monomethyl-L-arginine (L-NMMA) in the rat. Concurrent administration of aminoguanidine. (12.5-50 mg/kg, s.c.) with endotoxin (E. coli lipopolysaccharide, 3 mg/kg, i.v.), dose dependently increased vascular leakage of radiolabelled albumin in the ileum and colon after 1 h, an effect reversed by the pretreatment with L-arginine (300 mg/kg, s.c.). Aminoguanidine (50 mg/kg, s.c.) also elevated arterial blood pressure over the 1 h investigation period. Similar acute potentiation of endotoxin-provoked vascular injury was observed 1 h following L-NMMA (50 mg/kg s.c.) which also increased blood pressure, indicating the inhibition of constitutive NO synthase. By contrast, administration of aminoguanidine (12.5-50 mg/kg, s.c.) 3 h after endotoxin, at the time of the expression of the inducible NO synthase, reduced the subsequent endotoxin-induced vascular leakage, as did L-NMMA (50 mg/kg). In homogenates of rat ileal or colonic tissue, aminoguanidine inhibited both the constitutive and inducible NO synthase activity showing only 2-fold selectivity for the inducible isoform. Thus, although aminoguanidine inhibits these isoforms of NO synthase, it is not a selective inhibitor of the inducible isoform in the intestinal microvasculature in vivo.
Similar articles
- Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
Laszlo F, Whittle BJ, Moncada S. Laszlo F, et al. Br J Pharmacol. 1994 Apr;111(4):1309-15. doi: 10.1111/j.1476-5381.1994.tb14887.x. Br J Pharmacol. 1994. PMID: 7518298 Free PMC article. - The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat.
Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJ, Moncada S. Boughton-Smith NK, et al. Br J Pharmacol. 1993 Nov;110(3):1189-95. doi: 10.1111/j.1476-5381.1993.tb13940.x. Br J Pharmacol. 1993. PMID: 7507778 Free PMC article. - Aminoguanidine selectively inhibits inducible nitric oxide synthase.
Griffiths MJ, Messent M, MacAllister RJ, Evans TW. Griffiths MJ, et al. Br J Pharmacol. 1993 Nov;110(3):963-8. doi: 10.1111/j.1476-5381.1993.tb13907.x. Br J Pharmacol. 1993. PMID: 7507781 Free PMC article. - Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC, Chen SJ, Szabó C, Thiemermann C, Vane JR. Wu CC, et al. Br J Pharmacol. 1995 Apr;114(8):1666-72. doi: 10.1111/j.1476-5381.1995.tb14955.x. Br J Pharmacol. 1995. PMID: 7541282 Free PMC article. - Inhibition of nitric oxide formation by guanidines.
Hasan K, Heesen BJ, Corbett JA, McDaniel ML, Chang K, Allison W, Wolffenbuttel BH, Williamson JR, Tilton RG. Hasan K, et al. Eur J Pharmacol. 1993 Nov 2;249(1):101-6. doi: 10.1016/0014-2999(93)90667-7. Eur J Pharmacol. 1993. PMID: 7506664
Cited by
- Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.
Obermeier F, Kojouharoff G, Hans W, Schölmerich J, Gross V, Falk W. Obermeier F, et al. Clin Exp Immunol. 1999 May;116(2):238-45. doi: 10.1046/j.1365-2249.1999.00878.x. Clin Exp Immunol. 1999. PMID: 10337013 Free PMC article. - Distribution of NOS isoforms in a porcine endotoxin shock model.
Doursout MF, Oguchi T, Fischer UM, Liang Y, Chelly B, Hartley CJ, Chelly JE. Doursout MF, et al. Shock. 2008 Jun;29(6):692-702. doi: 10.1097/shk.0b013e3181598b77. Shock. 2008. PMID: 17909454 Free PMC article. - Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase.
Kis A, Végh A, Papp J, Parratt J. Kis A, et al. Br J Pharmacol. 1999 Aug;127(7):1545-50. doi: 10.1038/sj.bjp.0702695. Br J Pharmacol. 1999. PMID: 10455308 Free PMC article. - Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
Imagawa J, Yellon DM, Baxter GF. Imagawa J, et al. Br J Pharmacol. 1999 Feb;126(3):701-8. doi: 10.1038/sj.bjp.0702368. Br J Pharmacol. 1999. PMID: 10188982 Free PMC article. - Nitric oxide signals are interlinked with calcium signals in normal pancreatic stellate cells upon oxidative stress and inflammation.
Jakubowska MA, Ferdek PE, Gerasimenko OV, Gerasimenko JV, Petersen OH. Jakubowska MA, et al. Open Biol. 2016 Aug;6(8):160149. doi: 10.1098/rsob.160149. Open Biol. 2016. PMID: 27488376 Free PMC article.